Company Overview of Kareus Therapeutics, SA
Kareus Therapeutics, SA, a biotechnology company, discovers and develops small molecules as mono or combination therapy for the unmet treatment of age-related and chronic diseases. It discovers drugs for Alzheimer’s, cardiovascular, metabolic, and inflammatory diseases. The company has a strategic drug development alliance with Quintiles. Kareus Therapeutics, SA is based in La Chaux-de-Fonds, Switzerland.
40 Rue Fritz-Courvoisier
La Chaux-de-Fonds, 2300
41 32 967 90 24
41 32 967 95 96
Key Executives for Kareus Therapeutics, SA
Kareus Therapeutics, SA does not have any Key Executives recorded.
Similar Private Companies By Industry
|AB2 Bio Ltd.||Europe|
|ADC Products Switzerland SARL||Europe|
|ADC Therapeutics SA||Europe|
|AlloCyte Pharmaceuticals AG||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Kareus Therapeutics, SA, please visit www.kareustherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.